Medical Device Penetration Testing for Surgical Robotics
Penetration testing built for surgical robotic systems - teleoperation, real-time control loops, ROS-based stacks, and instrument arms. FDA-aligned reports.
Aligned to FDA's February 3, 2026 premarket cybersecurity guidance.
Surgical robotic systems concentrate three of the highest-risk attack surfaces in MedTech into one product: a real-time motion control loop, a teleoperation channel where surgeon input is digitized over a network, and an integration tower that talks to OR networks, imaging, and energy generators. A control-loop bug doesn't manifest as data loss - it manifests as a tool moving where it shouldn't. We test surgical robotics the way an attacker would attack one: from the surgeon console down through the network fabric into the patient cart, and from the OR network back up into the integration tower.
Many surgical robotic stacks ship on a Linux base with ROS or ROS2, custom RT kernels, and a mix of EtherCAT/CAN/proprietary buses to the joint controllers. ROS topic discovery is unauthenticated by default; without DDS Security profiles enabled, anyone on the same VLAN can inject pose commands or sniff kinematics telemetry. We exercise that path explicitly. We also probe the teleoperation latency budget: control loops that drop packets and fail-open instead of fail-safe become weaponizable. Finally, we test the integration tower's network exposure - service ports left open for field service, hardcoded engineering credentials, and unauthenticated firmware update endpoints - because that's how field teams have historically been compromised. Findings are mapped to ANSI/AAMI SW96 and IEC 60601-1 risk control requirements so your regulatory team can defend them in submission.
Layers we exercise in this engagement
The surgical robotics system, from the outermost cloud and clinician surfaces down to the device itself. Highlighted layers are exercised by this medical device penetration testing services.
- 01OR network
- 02Integration tower Tested
- 03Surgeon console Tested
- 04Patient cart / ROS Tested
- 05Joint controllers Tested
- 06Imaging / energy pass-through Tested
Layers shown outermost (top) to innermost (bottom). Dashed rows are part of the surrounding system but out of scope for this view.
Medical Device Penetration Testing Services engagement, end to end
Four phases, fixed fee, scoped to surgical robotics architecture from kickoff onward.
- 01
Scope + kickoff
Architecture review, attack-surface walkthrough, and threat-model alignment with your team. A written proposal within 24 hours.
- 02
Threat-model alignment
Every STRIDE entry in your threat model is matched to a planned test case so reviewers see one-to-one coverage.
- 03
Test execution
Device, cloud, mobile, BLE/RF, and OTA channels exercised in parallel by senior engineers - not a single web-app scan.
- 04
Submission-formatted report plus retest
eSTAR-format report with findings, CVSS 4.0 scores, remediation, and retests until every finding with uncontrolled risk is closed.
Findings we test for
Attack paths that can affect surgical robotics systems.
ROS / DDS topics on the patient-cart LAN can lack authentication
DDS Security profiles can be disabled in production builds. A laptop on the same switch port can publish joint-velocity commands that the arm processes before the watchdog trips.
Teleoperation channel can fail open under packet loss
The surgeon-console to patient-cart link can drop to zero velocity without engaging brakes when sequence numbers gap. A network-side attacker can use this behavior to freeze position at an attacker-chosen pose.
Engineering shell on the integration tower can remain accessible
A vendor service account with a fixed password can remain reachable on a non-default TCP port in customer deployments.
Firmware update endpoint can accept unsigned bundles
Joint-controller microcontrollers can receive updates over an internal CAN bridge with CRC-only integrity. Signed firmware can be enforced for the main compute node but not for the safety-critical motor controllers.
Imaging / energy-generator pass-through can trust upstream sources without authentication
DICOM and energy-device command streams can be forwarded without authenticating the source. A compromised imaging node can issue commands the robot interprets as surgeon-originated.
Public surgical robotics cybersecurity history
Recalls, CISA ICS-MA advisories, and disclosed research that shape what reviewers ask about in this segment - and what our scope is built to cover.
"Blue Goat Cyber takes the burden off our engineers and makes FDA cybersecurity requirements easy to understand. Their expertise and smooth process mean we can focus on our product, not the paperwork. The organized documentation, perfectly formatted for eSTAR, saves us countless hours."
Standard Medical Device Penetration Testing Services deliverables
The same deliverables the parent Medical Device Penetration Testing Services service ships with - tuned to your surgical robotics architecture.
- Device, firmware, and embedded testing: hardware teardown, JTAG/UART/SPI bus access, firmware extraction and reverse engineering, and exploitation of the secure boot, debug, and update paths. Done by operators who have tested infusion pumps, monitors, surgical robots, and implantables.
- Companion app and cloud API coverage: iOS/Android binary analysis, BLE pairing/GATT attacks, REST/MQTT/gRPC fuzzing, authentication and authorization testing, and tenant-isolation checks. We test the device as patients and clinicians actually use it, not in isolation.
- penetration test reports structured for FDA premarket submissions: executive summary, methodology, CVSS-scored findings tied to your threat model, reproduction steps, and documented tester independence, scope, methods, and results. Reviewer-ready, not a generic IT security PDF.
- Remediation guidance and re-test included: written fix recommendations per finding, engineer-to-engineer support during remediation, and unlimited retests until every finding with uncontrolled risk is closed, inside the fixed fee. Accepted residual risks remain documented in your risk file.
What lands in your eSTAR submission
Documents structured for the cybersecurity attachments of your submission - no reformatting on your side.
- Device, firmware, and embedded testing: hardware teardown, JTAG/UART/SPI bus access, firmware extraction and reverse engineering, and exploitation of the secure boot, debug, and update paths. Done by operators who have tested infusion pumps, monitors, surgical robots, and implantables.
- Companion app and cloud API coverage: iOS/Android binary analysis, BLE pairing/GATT attacks, REST/MQTT/gRPC fuzzing, authentication and authorization testing, and tenant-isolation checks. We test the device as patients and clinicians actually use it, not in isolation.
- penetration test reports structured for FDA premarket submissions: executive summary, methodology, CVSS-scored findings tied to your threat model, reproduction steps, and documented tester independence, scope, methods, and results. Reviewer-ready, not a generic IT security PDF.
- Remediation guidance and re-test included: written fix recommendations per finding, engineer-to-engineer support during remediation, and unlimited retests until every finding with uncontrolled risk is closed, inside the fixed fee. Accepted residual risks remain documented in your risk file.
Standards that apply
The Surgical Robotics baseline, plus the call-outs that matter for medical device penetration testing services in this segment.
Segment-specific call-outs
IEC 60601-1 + 60601-2-77 (robotically assisted surgical equipment)
Cyber findings that affect motion or energy delivery must be analyzed as risk controls under your essential performance, not just as IT findings.
DDS Security (OMG)
If your stack uses ROS2, be ready to show whether DDS Security authentication, access control, and cryptographic profiles are enabled in production - not just available.
What's not in scope
We scope tightly on purpose. These items are either out-of-scope by design or belong in a separate engagement - we'll tell you up front, not after kickoff.
- Hospital enterprise IT network penetration testing
- Clinical efficacy or human-factors validation
- Physical security of manufacturing sites
- Source-code review (unless explicitly added as a separate engagement)
Medical Device Penetration Testing Services for Surgical Robotics - FAQs
The questions buyers in this segment actually ask before scoping a medical device penetration testing services engagement.
Go deeper on Surgical Robotics and premarket
A practical, ungated buyer's guide for medical device manufacturers evaluating cybersecurity partners, what goes wrong, why it costs you, and what to demand from your next engagement. Aligned to the FDA February 2026 premarket guidance.
The most common high- and critical-severity findings we surface in medical device penetration tests, what each one looks like in the field, and how to fix it before your FDA submission.
A practical, ungated guide to the threat modeling gaps that trigger FDA cybersecurity questions in 510(k), De Novo, and PMA submissions - and exactly how to close them before reviewers find them.
Medical device cybersecurity should scale with device risk. Christian Espinosa argues why meeting only the Section 524B minimum leaves patients and submissions exposed.
VEX resources for medical device teams: a document guide, SBOM comparison, and common assessment mistakes, with evidence-based status and regulatory context.
Medical device cybersecurity for nanotech neurostimulation: a fictional STRIDE threat model linking controller risks, patient harms, controls, and testing.
Other engagements for Surgical Robotics
Teams in this segment commonly bundle these alongside medical device penetration testing services.
Keep going
Scope a Medical Device Penetration Testing Services engagement for your surgical robotics program.
A 30-minute discovery call with Christian Espinosa, Founder and CEO, and Kristy Kennedy, VP of Sales.